BI 44370 TA in Acute Migraine Attack

Mise à jour : Il y a 4 ans
Référence : NCT00751803

Femme et Homme

Extrait

The objective of this trial is to assess the safety, tolerability, and efficacy of three doses of BI 44370 TA in the treatment of patients with an acute migraine attack and headache pain of moderate or severe intensity, compared to placebo and an active comparator.


Critère d'inclusion

  • Migraine Disorders


Liens